Immune profiling of γδ T cells after human intestinal transplantation
人肠道移植后 γδ T 细胞的免疫分析
基本信息
- 批准号:10351494
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAllograftingAntigen-Presenting CellsAntigensAttenuatedB-Cell Antigen ReceptorBlood CirculationBone MarrowBone Marrow CytometryCD8B1 geneCellsChimerismClinicalClone CellsCytometryDataDevelopmentEngraftmentEquilibriumEragrostisGastrointestinal tract structureGene Expression ProfileGoalsGraft RejectionHematopoietic SystemHematopoietic stem cellsHigh-Throughput Nucleotide SequencingHost DefenseHost vs Graft ReactionHumanImmuneImmune ToleranceImmune responseImmunologic SurveillanceInfectionIntestinesInvestigationJournalsLifeLinkLiverLymphocyteMediatingMixed Lymphocyte Culture TestMucous MembraneOrganOrgan TransplantationOutcomePatternPhenotypePhysiologicalPrivatizationProceduresProgenitor Cell EngraftmentPropertyQuality of lifeRecording of previous eventsResearchRodentRoleSavingsShapesT memory cellT-Cell ReceptorT-LymphocyteT-cell receptor repertoireTechnologyTestingTissuesTransplant RecipientsTransplantationWorkallograft rejectionclinical investigationcomplementarity-determining region 3cytotoxiceffector T cellgastrointestinal transplantationgenomic platformimprovedinsightnext generation sequencingnovelnovel strategiespathogenperipheral bloodreconstitutionresponsesingle-cell RNA sequencingtraffickingγδ T cells
项目摘要
PROJECT SUMMARY
γδ T cells can recognize diverse antigens and exert disparate functions. The innate- and adaptive-like features
of human γδ T cells may be driven by differential γδ T cell receptor (TCR) repertoires, which can be shaped by
tissue compartmentalization, age and history of antigen exposure. Despite comprising a significant proportion
of resident T cells in many organs, including gut and liver, γδ T cells and their possible role in transplantation
outcomes are largely under‐researched. Our overarching goals are to elucidate the fundamental
mechanisms of how γδ T cells participate in allograft rejection and host defense after human intestinal
transplantation (ITx). We revealed that clinical outcomes after ITx are largely determined by the balance
between graft-versus-host (GvH) and host-versus-graft (HvG) alloreactivities, using an approach that identifies
alloreactive T cell clones following pre-Tx mixed lymphocyte reactions on the basis of TCRβ CDR3 high
throughput sequencing (TCRβ-seq). We showed that GvH-reactive αβ T cells, expanded from preexisting
donor resident memory T cells (TRM) after encountering rapidly-repopulating recipient antigen-presenting cells
in the graft mucosa, acquire effector T cell (Teff) functions and migrate into circulation and bone marrow (BM),
where they attenuate HvG responses, facilitate donor cell engraftment and control rejection. Using single cell
RNA-seq, we found that BM-infiltrating donor γδ T cells, dominated by “public” Vδ2 clonotypes, showed
cytotoxic Teff phenotypes similar to CD8 αβ T cells, suggesting their potential to also attenuate HvG reactions
and make space for donor hematopoietic stem and progenitor cell engraftment. We found that recipient γδ T
cells gradually populated the allograft, undergoing phenotypic changes from Teff to TRM, mainly with “private”
Vδ1 clonotypes. We hypothesize that γδ T cells not only participate in host defense against pathogens, but
also have the potential to modulate two-way alloresponses after human ITx. We now propose a study of
phenotypic and clonal tracking of human γδ T cells locally and systemically after ITx and further investigation of
their regulatory roles on alloreactivity and association with graft outcomes. We propose to pursue three
Specific Aims: To determine the chimerism, phenotype and clonotype of donor- (Aim 1) and recipient- (Aim 2)
derived γδ T cells in graft mucosa, circulation and BM by flow cytometry, mass cytometry and TCRγδ-seq. Bulk
TCRγδ-seq of pre-Tx unstimulated and ex vivo-stimulated γδ T cell repertoires and post-Tx γδ T cell
repertoires in the circulation, intestinal allograft and BM of ITx patients will be linked with single cell
transcriptional profiles of γδ T cell using the iRepertoire and 10x Genomics platforms (Aim 3). Our proposed
research will provide a deeper understanding of the mechanisms behind γδ T cell chimerism, maturation of
TRM features, and their modulatory roles on local and systemic alloresponses, facilitating the development of
novel strategies to regulate γδ T cells to overcome rejection, infection and increase the utilization of ITx as a
life-saving, quality of life-improving procedure.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianing Fu其他文献
Jianing Fu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianing Fu', 18)}}的其他基金
Immune profiling of γδ T cells after human intestinal transplantation
人肠道移植后 γδ T 细胞的免疫分析
- 批准号:
10493378 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 24.3万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 24.3万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 24.3万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 24.3万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 24.3万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 24.3万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 24.3万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 24.3万 - 项目类别: